Plasma AM2 levels were higher in patients with prostate cancer than in healthy individuals, and those patients showing a Gleason score ≥7, organ unconfined, seminal vesicle invasion, tumor node metastasis stage T2, positive lymph node, or extra-prostatic extension showed a higher level of AM2 [272]. The gene discussed is ADM2; the disease is prostate cancer.